Respiratory illness levels, including COVID, RSV and flu are increasing nationwide, according to Sanford Health and the CDC.

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

With rising cases of flu, COVID, RSV, and norovirus, older adults must take essential precautions to stay safe during the Quad-emic. Learn about preventive measures like vaccination, masking, and ...

Respiratory syncytial virus (RSV) leads to over 30 million severe respiratory infections, 3.5 million hospitalizations, and 100,000 deaths among children under five each year globally. Nearly half of ...

Respiratory Syncytial Virus, or RSV, has dominated headlines with an influx of cases across the country and here in Western ...

Respiratory illnesses like RSV, COVID-19, flu, and the common cold spike annually. Johns Hopkins experts debunk myths and ...

Meanwhile, COVID-19 markers declined or remained stable. ED visits for COVID are at low levels but are highest among young ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

This programme aims to ensure that most eligible older adults in the catch-up cohort are vaccinated within the first 12 months of the programme. Practices can support this by continuing to invite ...

The ACIP-approved immunization schedules for children and adolescents and for adults for 2025 have been published.